Clinical Trial Update: Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on allogeneic stem cell transplantation after chemotherapy in patients with hemoglobinopathies. The study, including sickle cell d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobinopathies
• Sickle Cell Disease
• Thalassemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hemoglobinopathies, Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-03-12